Tango Therapeutics TNGX
NASDAQ TNGX
$25.24 +0.94 (+3.87%)
As of: Nov 11, 2026 · 10:49 AM EST

Tango Therapeutics (TNGX) Return on Equity [ROE] (2021 - 2026)

Updated

Tango Therapeutics (TNGX) posted Return on Equity [ROE] of -17.47% for Q2 2026, up 79.00 percentage points from -96.47% a year earlier and up 11.59 percentage points from the prior quarter.

Analysis

Tango Therapeutics (TNGX) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

For FY2025, Tango Therapeutics' Return on Equity [ROE] came in at -37.23%, up 20.34 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a four-year change of -6.85 percentage points (FY2021 to FY2025).
  • In prior years, Tango Therapeutics' Return on Equity [ROE] was -57.58% in FY2024 (-17.09 pp), -40.49% in FY2023 (-4.06 pp), -36.42% in FY2022 (-6.04 pp) and -30.39% in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Return on Equity [ROE] since Q4 2021.
  • On a year-over-year basis, Return on Equity [ROE] has increased in each of the last three quarters, with an average year-over-year change of +1.65 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q2 2026, with a gain of 79.00 percentage points; the weakest was Q2 2025, with a drop of 50.98 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -29.06% (Q1 2026), -40.12% (Q4 2025) and -68.12% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Tango Therapeutics 4.12 Bn 1.40 Bn - -20.84%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -20.84%
Jun 30, 2026 -17.60%
Mar 31, 2026 -29.19%
Dec 31, 2025 -40.23%
Sep 30, 2025 -68.59%
Jun 30, 2025 -96.21%
Mar 31, 2025 -71.98%
Dec 31, 2024 -60.72%
Sep 30, 2024 -51.15%
Jun 30, 2024 -45.03%
Mar 31, 2024 -42.39%
Dec 31, 2023 -36.95%
Sep 30, 2023 -39.17%
Jun 30, 2023 -47.25%
Mar 31, 2023 -46.05%
Dec 31, 2022 -42.53%
Sep 30, 2022 -37.08%
Jun 30, 2022 -31.03%
Mar 31, 2022 -21.36%
Dec 31, 2021 -15.56%
API Access

Tango Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TNGX&period=max&api_key=YOUR_API_KEY